Bioanalytical Systems, Inc.   Report issue

For profit Phase 1 Phase 2
Founded: West Lafayette IN United States (1974)

Organization Overview

First Clinical Trial
2006
NCT00534378
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

BASi (Bioanalytical Systems, Inc.)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Disease (Phase 2)

Seizures (Phase 1)

Syndrome (Phase 2)

Tic Disorders (Phase 2)

Tics (Phase 2)

Tourette Syndrome (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 14
  • # of Trial APIs: 12